These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8388193)

  • 1. Efficacy and ocular penetration of sparfloxacin in experimental streptococcal endophthalmitis.
    Cochereau-Massin I; Bauchet J; Marrakchi-Benjaafar S; Saleh-Mghir A; Faurisson F; Vallois JM; Vallee E; Pocidalo JJ
    Antimicrob Agents Chemother; 1993 Apr; 37(4):633-6. PubMed ID: 8388193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic prophylaxis of experimental staphylococcal endophthalmitis: comparative efficacy of sparfloxacin, pefloxacin, imipenem, vancomycin, and amikacin.
    Marrakchi-Benjaafar S; Cochereau I; Pocidalo JJ; Carbon C
    J Infect Dis; 1995 Nov; 172(5):1312-6. PubMed ID: 7594669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of sparfloxacin and autoradiographic diffusion pattern of [14C]Sparfloxacin in experimental Staphylococcus aureus joint prosthesis infection.
    Crémieux AC; Mghir AS; Bleton R; Manteau M; Belmatoug N; Massias L; Garry L; Sales N; Mazière B; Carbon C
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2111-6. PubMed ID: 8878590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal trovafloxacin against experimental Staphylococcus epidermidis endophthalmitis.
    Karaküçük S; Mirza E; Sümerkan B; Okten T
    Ophthalmic Res; 2000; 32(2-3):126-31. PubMed ID: 10754446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraocular pharmacokinetics of intravenously administered marbofloxacin in rabbits with experimentally induced acute endophthalmitis.
    Regnier A; Schneider M; Concordet D; Toutain PL
    Am J Vet Res; 2008 Mar; 69(3):410-5. PubMed ID: 18312141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of experimental Staphylococcus epidermidis endophthalmitis with oral trovafloxacin.
    Ng EW; Samiy N; Ruoff KL; Cousins FV; Hooper DC; von Gunten S; D'Amico DJ; Baker AS
    Am J Ophthalmol; 1998 Aug; 126(2):278-87. PubMed ID: 9727522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of sparfloxacin in the serum and vitreous humor of rabbits: physicochemical properties that regulate penetration of quinolone antimicrobials.
    Liu W; Liu QF; Perkins R; Drusano G; Louie A; Madu A; Mian U; Mayers M; Miller MH
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1417-23. PubMed ID: 9624487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal pefloxacin therapy in postoperative endophthalmitis.
    Kumar A; Sridhar MS; Dada T; Tewari HK; Gupta SK
    Clin Exp Ophthalmol; 2000 Feb; 28(1):38-40. PubMed ID: 11345344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of intravitreal administrations of linezolid in an experimental model of S. aureus-related endophthalmitis.
    Saleh M; Lefèvre S; Acar N; Bourcier T; Marcellin L; Prévost G; Subilia A; Gaucher D; Jehl F
    Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4832-41. PubMed ID: 22661478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerability, kinetics, and efficacy of subconjunctival pefloxacin in pigmented rabbits.
    Marrakchi-Benjaafar S; Cochereau I; D'Hermies F; Pocidalo JJ
    Antimicrob Agents Chemother; 1995 Apr; 39(4):834-8. PubMed ID: 7785980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intravitreal triamcinolone acetonide on susceptibility to experimental bacterial endophthalmitis and subsequent response to treatment.
    Bucher RS; Hall E; Reed DM; Richards JE; Johnson MW; Zacks DN
    Arch Ophthalmol; 2005 May; 123(5):649-53. PubMed ID: 15883284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical 0.5% moxifloxacin prevents endophthalmitis in an intravitreal injection rabbit model.
    Kowalski RP; Romanowski EG; Mah FS; Yates KA; Gordon YJ
    J Ocul Pharmacol Ther; 2008 Feb; 24(1):1-7. PubMed ID: 18370872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sparfloxacin therapy for experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
    Maserati R; Cagni AE; Segú C
    Chemotherapy; 1996; 42(2):133-9. PubMed ID: 8697888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High dose intramuscular methylprednisolone in experimental Staphylococcus aureus endophthalmitis.
    Yoshizumi MO; Kashani A; Palmer J; Lee G; Mondino B
    J Ocul Pharmacol Ther; 1999 Feb; 15(1):91-6. PubMed ID: 10048352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of topical lomefloxacin against experimental Pseudomonas endophthalmitis in rabbits.
    Hatano H; Inoue K; Shia S; Liping W
    Acta Ophthalmol (Copenh); 1993 Oct; 71(5):666-70. PubMed ID: 8109214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moxifloxacin efficacy and vitreous penetration in a rabbit model of Staphylococcus aureus endophthalmitis and effect on gene expression of leucotoxins and virulence regulator factors.
    Bronner S; Jehl F; Peter JD; Ploy MC; Renault C; Arvis P; Monteil H; Prevost G
    Antimicrob Agents Chemother; 2003 May; 47(5):1621-9. PubMed ID: 12709331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of intravitreal piperacillin/tazobactam in rabbits with experimental Staphylococcus epidermidis endophthalmitis: a comparison with vancomycin.
    Ozkiriş A; Evereklioglu C; Eşel D; Akgün H; Erkiliç K
    Ophthalmic Res; 2005; 37(3):168-74. PubMed ID: 15942265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Staphylococcus epidermidis endophthalmitis with intravitreal moxifloxacin in a rabbit model.
    Ermis SS; Cetinkaya Z; Kiyici H; Ozturk F
    Tohoku J Exp Med; 2005 Mar; 205(3):223-9. PubMed ID: 15718814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of sparfloxacin, temafloxacin, and ciprofloxacin for prophylaxis and treatment of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.
    Cagni A; Chuard C; Vaudaux PE; Schrenzel J; Lew DP
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1655-60. PubMed ID: 7486895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracameral Vigamox (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model.
    Kowalski RP; Romanowski EG; Mah FS; Yates KA; Gordon YJ
    Am J Ophthalmol; 2005 Sep; 140(3):497-504. PubMed ID: 16083841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.